| A Study of Modified mRNA Vaccines in Healthy Adults (NCT05397223) | ModernaTX, Inc. | 2022-05-24 |
| Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age (NCT05301322) | Pfizer | 2022-04-13 |
| A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age (NCT05330975) | ModernaTX, Inc. | 2022-04-01 |
| A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection (NCT04978337) | Janssen Research & Development, LLC | 2021-11-17 |
| A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age (NCT05127434) | ModernaTX, Inc. | 2021-11-17 |
| A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive (NCT04528719) | ModernaTX, Inc. | 2020-09-30 |
| A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects (NCT04196101) | Enanta Pharmaceuticals, Inc | 2020-01-22 |
| A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age (NCT03606512) | Janssen Vaccines & Prevention B.V. | 2019-01-21 |
| Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002) (NCT03524118) | Merck Sharp & Dohme LLC | 2018-09-20 |
| Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults (NCT03049488) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-02-22 |
| Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children (NCT02707523) | University of Alabama at Birmingham | 2016-01-01 |
| A Study to Evaluate the Efficacy of MEDI7510 in Older Adults (NCT02508194) | MedImmune LLC | 2015-09-29 |
| A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine (NCT02472548) | Dalhousie University | 2015-05-01 |
| Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract (NCT02254408) | Gilead Sciences | 2015-01-23 |
| A Phase 1b/2a Randomized, Double-Blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants (NCT02290340) | MedImmune LLC | 2015-01-13 |
| A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age (NCT01995175) | GlaxoSmithKline | 2013-12-12 |
| A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections (NCT02133092) | Janssen Research & Development, LLC | 2013-12-01 |
| A Study in Japanese Children Hospitalized With Respiratory Syncytial Virus Related Lower Respiratory Tract Infections (NCT02132923) | Janssen R&D Ireland | 2013-12-01 |
| Cough Assist in Bronchiolitis (NCT01757496) | University Hospital, Antwerp | 2012-09-01 |
| Sofia RSV FIA Field Study (NCT01734668) | Quidel Corporation | 2012-03-01 |
| MEDI-557 Adult Dosing (NCT01562938) | MedImmune LLC | 2012-03-01 |
| Respiratory Events Among Premature Infants (NCT00889070) | MedImmune LLC | 2008-11-01 |
| Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses (NCT00613184) | Kern Medical Center | 2006-11-01 |
| RSV Disease in the Elderly (NCT00246480) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-03 |
| RSV Challenge in Healthy Adults (NCT00100373) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-01 |